We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group, a Zacks Rank #1 (Strong Buy), is the world’s leading and most diverse derivatives marketplace. CME Group operates contract markets for the trading of futures and options worldwide. The company offers derivatives products based on interest rates, equities, foreign exchange, commodities, and fixed income through its electronic trading platforms.
The stock is displaying relative strength and has been making a series of 52-week highs this year. Shares have held up extremely well through the recent market volatility. Increasing volume has attracted investor attention as buying pressure accumulates in this top-ranked stock.
This year’s market action has witnessed a notable rotation in industry strength. It’s our job to identify that rotation and position our portfolios to benefit from it.
CME Group is part of the Zacks Securities and Exchanges industry group, which currently ranks in the top 15% out of more than 250 industries. Because this group is ranked in the top half of all Zacks Ranked Industries, we expect it to outperform the market over the next 3 to 6 months, just as it has so far this year:
Image Source: Zacks Investment Research
Historical research studies suggest that approximately half of a stock’s price appreciation is due to its industry grouping. In fact, the top 50% of Zacks Ranked Industries outperforms the bottom 50% by a factor of more than 2 to 1.
It’s no secret that investing in stocks that are part of leading industry groups can give us a leg up relative to the market. By focusing on leading stocks within the top industries, we can dramatically improve our stock-picking success.
Company Description
In addition to its operation of contract markets for the trading of derivatives, the Chicago, Illinois-based company provides clearing house services including clearing, settling, and guaranteeing of futures, options, and cleared swaps products through its exchanges. CME Group also provides trade processing and risk mitigation services.
The exchange offers a range of market data services including real-time and historical data. CME Group serves professional traders, financial institutions, corporations, governments and central banks. The company witnessed record activity in its cryptocurrency derivatives markets during the first quarter of the year, driven by micro-sized contracts.
CME Group boasts a strong market position driven by its diverse product line and numerous strategic alliances. Fundamental growth remains a key driver for the company’s operating leverage, as CME leads with about 90% market share of global futures trading and clearing services. While higher electronic trading volume adds scalability, product innovation and a growing proportion of volume from customers outside the United States have been driving results.
Earnings Trends and Future Estimates
CME Group (CME - Free Report) boasts a long history of surpassing earnings estimates. The company most recently delivered fourth-quarter earnings back in February of $2.52 per share, which represented a 3.28% surprise over the Zacks Consensus Estimate.
CME has delivered a trailing four-quarter average surprise of 2.2%. Consistently beating earnings estimates is a recipe for success.
Analysts covering CME have upped their current-quarter EPS estimates by 5.84% in the past 60 days. The Zacks Consensus Estimate now stands at $2.72 per share, translating to growth of 8.8% relative to the year-ago period.
Image Source: Zacks Investment Research
What the Zacks Model Reveals
The Zacks Earnings ESP (Expected Surprise Prediction) seeks to find companies that have recently witnessed positive earnings estimate revision activity. This more recent information can be a better predictor for future earnings and can give investors a leg up during earnings season.
The technique has proven to be quite useful for finding positive earnings surprises. In fact, when combining a Zacks Rank #3 or better with a positive Earnings ESP, stocks produced a positive surprise 70% of the time according to our 10-year back test.
CME Group is a Zacks Rank #1 (Strong Buy) and boasts a +3.87% Earnings ESP. Another beat may be in the cards when the company reports Q1 results on April 23rd.
Let’s Get Technical
This market leader has seen its stock advance more than 11% already this year, all while the general market remains in a correction. Only stocks that are in extremely powerful uptrends are able to experience this type of outperformance. This is the kind of stock we want to include in our portfolio – one that is trending well and receiving positive earnings estimate revisions.
Image Source: StockCharts
Notice how both the 50-day (blue line) and 200-day (red line) moving averages are sloping up. The stock has been making a series of higher highs throughout the past year. With both strong fundamental and technical indicators, CME stock is poised to continue its outperformance.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. As we know, CME Group has recently witnessed positive revisions. As long as this trend remains intact (and CME continues to deliver earnings beats), the stock will likely continue its bullish run.
Bottom Line
Backed by a leading industry group and history of earnings beats, it’s not difficult to see why CME stock is a compelling investment. Robust fundamentals combined with an appealing technical trend certainly justify adding shares to the mix.
CME is ranked favorably by our Zacks Momentum Style Score with a top ‘A’ rating. This indicates that shares are likely to move higher based on momentum in earnings and sales trends along with price performance.
Recent positive earnings estimate revisions should also serve to create a ‘floor’ in terms of any sudden or unexpected downside moves. If you haven’t already done so, be sure to put CME on your shortlist.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bull of the Day: CME Group (CME)
CME Group, a Zacks Rank #1 (Strong Buy), is the world’s leading and most diverse derivatives marketplace. CME Group operates contract markets for the trading of futures and options worldwide. The company offers derivatives products based on interest rates, equities, foreign exchange, commodities, and fixed income through its electronic trading platforms.
The stock is displaying relative strength and has been making a series of 52-week highs this year. Shares have held up extremely well through the recent market volatility. Increasing volume has attracted investor attention as buying pressure accumulates in this top-ranked stock.
This year’s market action has witnessed a notable rotation in industry strength. It’s our job to identify that rotation and position our portfolios to benefit from it.
CME Group is part of the Zacks Securities and Exchanges industry group, which currently ranks in the top 15% out of more than 250 industries. Because this group is ranked in the top half of all Zacks Ranked Industries, we expect it to outperform the market over the next 3 to 6 months, just as it has so far this year:
Image Source: Zacks Investment Research
Historical research studies suggest that approximately half of a stock’s price appreciation is due to its industry grouping. In fact, the top 50% of Zacks Ranked Industries outperforms the bottom 50% by a factor of more than 2 to 1.
It’s no secret that investing in stocks that are part of leading industry groups can give us a leg up relative to the market. By focusing on leading stocks within the top industries, we can dramatically improve our stock-picking success.
Company Description
In addition to its operation of contract markets for the trading of derivatives, the Chicago, Illinois-based company provides clearing house services including clearing, settling, and guaranteeing of futures, options, and cleared swaps products through its exchanges. CME Group also provides trade processing and risk mitigation services.
The exchange offers a range of market data services including real-time and historical data. CME Group serves professional traders, financial institutions, corporations, governments and central banks. The company witnessed record activity in its cryptocurrency derivatives markets during the first quarter of the year, driven by micro-sized contracts.
CME Group boasts a strong market position driven by its diverse product line and numerous strategic alliances. Fundamental growth remains a key driver for the company’s operating leverage, as CME leads with about 90% market share of global futures trading and clearing services. While higher electronic trading volume adds scalability, product innovation and a growing proportion of volume from customers outside the United States have been driving results.
Earnings Trends and Future Estimates
CME Group (CME - Free Report) boasts a long history of surpassing earnings estimates. The company most recently delivered fourth-quarter earnings back in February of $2.52 per share, which represented a 3.28% surprise over the Zacks Consensus Estimate.
CME has delivered a trailing four-quarter average surprise of 2.2%. Consistently beating earnings estimates is a recipe for success.
Analysts covering CME have upped their current-quarter EPS estimates by 5.84% in the past 60 days. The Zacks Consensus Estimate now stands at $2.72 per share, translating to growth of 8.8% relative to the year-ago period.
Image Source: Zacks Investment Research
What the Zacks Model Reveals
The Zacks Earnings ESP (Expected Surprise Prediction) seeks to find companies that have recently witnessed positive earnings estimate revision activity. This more recent information can be a better predictor for future earnings and can give investors a leg up during earnings season.
The technique has proven to be quite useful for finding positive earnings surprises. In fact, when combining a Zacks Rank #3 or better with a positive Earnings ESP, stocks produced a positive surprise 70% of the time according to our 10-year back test.
CME Group is a Zacks Rank #1 (Strong Buy) and boasts a +3.87% Earnings ESP. Another beat may be in the cards when the company reports Q1 results on April 23rd.
Let’s Get Technical
This market leader has seen its stock advance more than 11% already this year, all while the general market remains in a correction. Only stocks that are in extremely powerful uptrends are able to experience this type of outperformance. This is the kind of stock we want to include in our portfolio – one that is trending well and receiving positive earnings estimate revisions.
Image Source: StockCharts
Notice how both the 50-day (blue line) and 200-day (red line) moving averages are sloping up. The stock has been making a series of higher highs throughout the past year. With both strong fundamental and technical indicators, CME stock is poised to continue its outperformance.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. As we know, CME Group has recently witnessed positive revisions. As long as this trend remains intact (and CME continues to deliver earnings beats), the stock will likely continue its bullish run.
Bottom Line
Backed by a leading industry group and history of earnings beats, it’s not difficult to see why CME stock is a compelling investment. Robust fundamentals combined with an appealing technical trend certainly justify adding shares to the mix.
CME is ranked favorably by our Zacks Momentum Style Score with a top ‘A’ rating. This indicates that shares are likely to move higher based on momentum in earnings and sales trends along with price performance.
Recent positive earnings estimate revisions should also serve to create a ‘floor’ in terms of any sudden or unexpected downside moves. If you haven’t already done so, be sure to put CME on your shortlist.